Pharmala Biotech Holdings Inc. (CNSX: MDMA)
Health Care · Biotechnology · CA
CA$0.16
-27.91% today · +47.6% 1Y
Pharmala Biotech Holdings Inc. (CNSX: MDMA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $12.02M and employs 5 people.
Over the last twelve months the share price has gained 47.6%, trading between 0.09 and 0.33.
Tweenvest scores Pharmala Biotech Holdings Inc. across four factors: quality 50/100, value 58/100. Its strongest factor is value.
MDMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.02M
- Revenue (TTM)
- $919.56K
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 0.87
- 52-week high
- CA$0.33
- 52-week low
- CA$0.09
- Avg volume (3M)
- —
- Shares outstanding
- 109.68M
- Employees
- 5
- Next earnings
- —
About Pharmala Biotech Holdings Inc.
Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts on the research, manufacturing, and bringing to market of active pharmaceutical ingredients (APIs) within the substituted methylenedioxy-phenethylamine (MDXX) class. The company's offerings further extend to various MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB) and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), in addition to prepared formulations of these MDXX substances. The enterprise maintains its primary corporate offices in Vancouver, Canada.
- ISIN
- CA71719L1067
- Listed since
- Jan 11, 2022
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Clal Biotechnology Industries Ltd.TASE: CBI | $12.34M | ₪0.24 | +2.52% |
| Synlogic, Inc.OTCPK: SYBX | $12.25M | $1.00 | -9.09% |
| NextCell Pharma ABOM: NXTCL | $12.20M | Skr0.96 | -5.53% |
| Radiopharm Theranostics LimitedASX: RAD | $12.07M | AU$0.00 | -20.00% |
| EOM Pharmaceuticals Holdings, Inc.OTCPK: IMUC | $12.02M | $0.10 | -40.21% |
| Karyopharm Therapeutics Inc.NasdaqGS: KPTI | $11.74M | $0.52 | -5.27% |
| AEON Biopharma, Inc.NYSEAM: AEON | $11.57M | $0.23 | -15.94% |
| BioLineRx Ltd.TASE: BLRX | $11.56M | ₪0.01 | -7.69% |
Figures last refreshed Oct 18, 2026.